Nektium retains Deloitte to sell minority stake in the company
Nektium habría encargado a Deloitte la venta de una participación minoritaria de la compañía
Intel ID : 333190
|
||||
|
||||
| Intel ID | 333190 | ||
| Value | ND | ||
| Native Currency | Euro (EUR) | ||
|
Financial Data - Nektium
(31 Dec 2023) |
Revenue: EUR 14,78m EBITDA: EUR 2,06m People: 47 |
||
| Date |
 |
||
| Country |  |
||
| Geography | |
||
| Subsector (Old TTR Sectors) |
|
||
| Type |
|
||
| Intel Grade |
|
||
| Source |
|
||
| Tags | |
Target
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.01 Biopharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Financial Advisory
| Parties | Advisor | Notes from Advisors | |||||
|---|---|---|---|---|---|---|---|
|
|
- |
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.